BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 12387980)

  • 41. Treatment of oesophageal cancer with preoperative chemoradiotherapy may increase operative mortality.
    Balart J; Balmaña J; Rius X; Salazar R; Gallen M; Navarro S; Arcusa A; Gallardo E; Brunet J
    Eur J Surg Oncol; 2003 Dec; 29(10):884-9. PubMed ID: 14624782
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The role of neoadjuvant therapy in the treatment of locally advanced squamous cell cancer of the cervical oesophagus].
    Papp A; Cseke L; Varga G; Pavlovics G; Potó L; Márton S; Farkas R; Bellyei S; Horváth OP
    Magy Seb; 2012 Oct; 65(5):340-7. PubMed ID: 23086818
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Principles of neoadjuvant therapy].
    Lordick F
    Chirurg; 2009 Nov; 80(11):1000-5. PubMed ID: 19812908
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Patterns of failure following combined modality therapy for esophageal cancer, 1984-1990.
    Kavanagh B; Anscher M; Leopold K; Deutsch M; Gaydica E; Dodge R; Allen K; Allen D; Staub W; Montana G
    Int J Radiat Oncol Biol Phys; 1992; 24(4):633-42. PubMed ID: 1429085
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chemoradiotherapy of esophageal carcinoma.
    Poplin EA; Khanuja PS; Kraut MJ; Herskovic AM; Lattin PB; Cummings G; Gaspar LE; Kinzie JL; Steiger Z; Vaitkevicius VK
    Cancer; 1994 Aug; 74(4):1217-24. PubMed ID: 8055441
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prospective non-randomized trial comparing esophagectomy-followed-by-chemoradiotherapy versus chemoradiotherapy-followed-by-esophagectomy for T4 esophageal cancers.
    Fujita H; Sueyoshi S; Tanaka T; Tanaka Y; Sasahara H; Shirouzu K; Suzuki G; Hayabuchi N; Inutsuka H
    J Surg Oncol; 2005 Jun; 90(4):209-19. PubMed ID: 15906363
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Neoadjuvant therapy of adenocarcinomas of the upper gastrointestinal tract. Status of radiotherapy].
    Semrau R; Vallböhmer D; Hölscher AH; Müller RP
    Chirurg; 2009 Nov; 80(11):1035-41. PubMed ID: 19820906
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An appropriate esophagectomy for esophageal cancer: a lack of evidence and a growing disparity between Western and Eastern standards.
    Nishimaki T
    Ann Thorac Cardiovasc Surg; 2006 Aug; 12(4):231-3. PubMed ID: 16977290
    [No Abstract]   [Full Text] [Related]  

  • 49. Concurrent chemoradiotherapy with twice weekly paclitaxel and cisplatin followed by esophagectomy for locally advanced esophageal cancer.
    Lin CC; Hsu CH; Cheng JC; Wang HP; Lee JM; Yeh KH; Yang CH; Lin JT; Cheng AL; Lee YC
    Ann Oncol; 2007 Jan; 18(1):93-98. PubMed ID: 17028244
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cetuximab in combination with chemoradiotherapy before surgery in patients with resectable, locally advanced esophageal carcinoma: a prospective, multicenter phase IB/II Trial (SAKK 75/06).
    Ruhstaller T; Pless M; Dietrich D; Kranzbuehler H; von Moos R; Moosmann P; Montemurro M; Schneider PM; Rauch D; Gautschi O; Mingrone W; Widmer L; Inauen R; Brauchli P; Hess V
    J Clin Oncol; 2011 Feb; 29(6):626-31. PubMed ID: 21205757
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Concurrent cisplatin, 5-FU, paclitaxel, and radiation therapy in patients with locally advanced esophageal cancer.
    Roof KS; Coen J; Lynch TJ; Wright C; Fidias P; Willett CG; Choi NC
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1120-8. PubMed ID: 16730135
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preoperative combined modality therapy with paclitaxel, carboplatin, prolonged infusion 5-fluorouracil, and radiation therapy in localized esophageal cancer: preliminary results of a Minnie Pearl Cancer Research Network phase II trial.
    Meluch AA; Hainsworth JD; Gray JR; Thomas M; Whitworth PL; Davis JL; Greco FA
    Cancer J Sci Am; 1999; 5(2):84-91. PubMed ID: 10198730
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Weekly chemotherapy with cisplatin and paclitaxel and concurrent radiation therapy as preoperative treatment in locally advanced esophageal cancer: a phase II study.
    Orditura M; Galizia G; Napolitano V; Martinelli E; Pacelli R; Lieto E; Aurilio G; Vecchione L; Morgillo F; Catalano G; Ciardiello F; Del Genio A; Di Martino N; De Vita F
    Cancer Invest; 2010 Oct; 28(8):820-7. PubMed ID: 20482249
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A pilot study of neoadjuvant chemotherapy with 5-fluorouracil and cisplatin with surgical resection and postoperative radiation therapy and/or chemotherapy in adenocarcinoma of the esophagus.
    Carey RW; Hilgenberg AD; Choi NC; Mathisen DJ; Grillo HC; Wain JC; Logan DL; Bromberg C
    Cancer; 1991 Aug; 68(3):489-92. PubMed ID: 2065268
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Morbidity and mortality after surgery for cancer of the oesophagus and gastro-oesophageal junction: A randomized clinical trial of neoadjuvant chemotherapy vs. neoadjuvant chemoradiation.
    Klevebro F; Johnsen G; Johnson E; Viste A; Myrnäs T; Szabo E; Jacobsen AB; Friesland S; Tsai JA; Persson S; Lindblad M; Lundell L; Nilsson M
    Eur J Surg Oncol; 2015 Jul; 41(7):920-6. PubMed ID: 25908010
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phase 2 trial of preoperative irinotecan plus cisplatin and conformal radiotherapy, followed by surgery for esophageal cancer.
    Knox JJ; Wong R; Visbal AL; Horgan AM; Guindi M; Hornby J; Xu W; Ringash J; Keshavjee S; Chen E; Haider M; Darling G
    Cancer; 2010 Sep; 116(17):4023-32. PubMed ID: 20533506
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The effect of preoperative chemo-radiotherapy in the treatment of locally advanced squamous cell carcinoma in the upper- and middle-thirds of the esophagus].
    Papp A; Cseke L; Pavlovics G; Farkas R; Varga G; Márton S; Pótó L; Esik O; Horváth OP
    Magy Seb; 2007; 60(3):123-9. PubMed ID: 17727214
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of neoadjuvant chemotherapy on circumferential margin positivity and its impact on prognosis in patients with resectable oesophageal cancer.
    Sujendran V; Wheeler J; Baron R; Warren BF; Maynard N
    Br J Surg; 2008 Feb; 95(2):191-4. PubMed ID: 17948302
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of the prognostic value of the 6th and 7th editions of the Union for International Cancer Control TNM staging system in patients with lower esophageal cancer undergoing neoadjuvant chemotherapy followed by surgery.
    Mehta SP; Jose P; Mirza A; Pritchard SA; Hayden JD; Grabsch HI
    Dis Esophagus; 2013; 26(2):182-8. PubMed ID: 22591020
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of neoadjuvant chemoradiotherapy in resectable esophageal squamous cell carcinoma--a single institutional study.
    Lee JL; Kim SB; Jung HY; Park SI; Kim DK; Kim JH; Song HY; Kim WK; Lee JS; Min YI
    Acta Oncol; 2003; 42(3):207-17. PubMed ID: 12852697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.